Show simple item record

dc.contributor.editorBerruti, Alfredo
dc.contributor.editorAmoroso, Vito
dc.contributor.editorFazio, Nicola
dc.date.accessioned2023-02-02T16:34:23Z
dc.date.available2023-02-02T16:34:23Z
dc.date.issued2023
dc.identifierONIX_20230202_9783036557632_76
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/96675
dc.description.abstractEndocrine and neuroendocrine tumors originate from endocrine cells but are heterogeneous in terms of clinical presentation, disease outcome, and treatments available. This Special Issue addresses specific aspects of pre-clinical, clinical, and translational research and clinical management of these diseases with the aim of providing novel insights, addressing current unmet needs, and discussing future treatment perspectives.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncologyen_US
dc.subject.otherneuroendocrine neoplasm
dc.subject.otherneuroendocrine carcinoma
dc.subject.otherKi67 labeling index
dc.subject.otherKi67 proliferation index
dc.subject.otheradrenocortical tissues
dc.subject.otherEMT
dc.subject.otherepithelial markers
dc.subject.othermesenchymal markers
dc.subject.otherrecurrence-free survival
dc.subject.otherneuroendocrine neoplasms
dc.subject.othermolecular targeted therapies
dc.subject.othermTOR inhibitors
dc.subject.othersomatostatin analogs
dc.subject.otherTPH inhibitors
dc.subject.othermeta-analysis
dc.subject.othermedullary thyroid cancer
dc.subject.othercalcitonin
dc.subject.otherMEN2
dc.subject.othergene carriers
dc.subject.otheradrenocortical cancer
dc.subject.othermetastatic pheochromocytoma
dc.subject.othermetastatic paraganglioma
dc.subject.othercheckpoint inhibitors
dc.subject.otheravelumab
dc.subject.otheripilimumab
dc.subject.othernivolumab
dc.subject.otherpembrolizumab
dc.subject.otherneuroendocrine tumor
dc.subject.otherGEP-NET
dc.subject.otherPET/CT
dc.subject.otherPRRT
dc.subject.otherDOTATOC
dc.subject.othercrcinoid crisis
dc.subject.otherneuroendocrine tumors
dc.subject.otherhemodynamic instability
dc.subject.otheroctreotide
dc.subject.otherneuroendocrine
dc.subject.othermolecular profiling
dc.subject.othertargeted therapies
dc.subject.othermutation
dc.subject.otherfusion
dc.subject.otherctDNA
dc.subject.otheranaplastic thyroid carcinoma
dc.subject.otherchemotherapy
dc.subject.otherimmune checkpoint inhibitors
dc.subject.othertumors associated macrophages
dc.subject.otherradiotherapy
dc.subject.othermolecular targeted therapy
dc.subject.othergastroenteropancreatic neuroendocrine neoplasms
dc.subject.otherpatient-derived xenograft
dc.subject.othertumor spheroids
dc.subject.othersomatostatin receptor-2
dc.subject.othernear infrared-labelled octreotide analog
dc.subject.othermanagement
dc.subject.otherDelphi
dc.subject.otherconsensus
dc.subject.otherpancreatic neuroendocrine tumor
dc.subject.othereverolimus
dc.subject.otherangiogenesis
dc.subject.othercirculating cells
dc.subject.otherbiomarkers
dc.subject.othern/a
dc.titleEndocrine and Neuroendocrine Cancers
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-5764-9
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036557632
oapen.relation.isbn9783036557649
oapen.pages198
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/